Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.

In addition to HBsAg, other viral markers such as hepatitis B core-related antigen (HBcrAg) are available, but their potential association with HBV-specific immune responses is not defined yet, which ...

Introduction: Achieving functional cure of chronic hepatitis B (CHB), characterized by the loss of HBV DNA and HBsAg, remains challenging in adults but demonstrates higher success rates in children.

这篇综述聚焦乙肝表面抗原（HBsAg）与肝细胞癌（HCC）。详细阐述了 HBsAg 在 HCC 发生、发展及术后复发中的作用机制，探讨其作为生物标志物的临床意义，还介绍了相关治疗药物，为 HCC 防治提供重要理论依据和研究方向。 ### 乙肝表面抗原与肝细胞癌的关联概述 ...

试验的初步结果显示，PBGENE-HBV 在以最低剂量水平进行 3 次静脉注射中的第一次给药后，3 名参与者中的 2 名（队列 1）的乙肝表面抗原（HBsAg）降低。 据Precision BioSciences称，3名受试者的感染年龄、感染持续时间和乙肝表面抗原（HBsAg）水平各不相同。接受治疗的 ...

A functional cure is said to have been achieved if a biomarker called hepatitis B surface antigen (HBsAg) is cleared from the blood and remains undetectable after stopping all treatment.

队列4的最新数据显示，过往产生BRII-179诱导的乙肝表面抗体(“抗-HBs”)应答的参与者，其HBsAg血清清除率显著高于未产生应答的参与者。第24周时 ...

慢性乙肝感染以血浆中持续检测到 HBV 表面抗原（HBsAg）为特征，HBsAg 检测是乙肝筛查的重要手段，但检测灵敏度受病毒基因型、亚型及基因组重组影响，低水平 HBsAg 可能检测不到。对于 HBsAg 阳性患者，HDV 诊断依赖血清学和分子检测，但 HDV 感染常被漏诊。

A functional cure is said to have been achieved if HBsAg is cleared from the blood and remains undetectable after stopping all treatment. In B-Clear, patients with low baseline HBsAg levels ...

Initial findings from the trial showed PBGENE-HBV reduced hepatitis B surface antigen (HBsAg) in 2 of the 3 participants after the first of 3 intravenous administrations at the lowest dose level ...

Vaccines Tobacco Hepatitis B virus surface antigen (HBsAg) produced in transgenic tobacco induces immune response when injected into mice Oral vaccines Maize Fusion protein (F) from Newcastle ...